Artificial Intelligence
-
Artificial Intelligence, BioPharma
AI Biotech Recursion Commits $88M to a Pair of Drug Discovery Acquisitions
Recursion Pharmaceuticals is acquiring two Canada-based artificial intelligence startups, Cyclica and Valence. The “biology-first company” says both deals build up its capability to apply AI to the chemistry side of drug discovery.
-
MedCity Influencers, Artificial Intelligence, Legal
Dentistry 2023: Making Patient Care a Premium
To positively impact the health of the most significant number of people, dentistry must be amplified by AI and truly become preventive care.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Devices & Diagnostics, Artificial Intelligence
Season 2 of MedCity Pivot Podcast Launches with Conversation of Zephyr AI CTO
Season 2 of our MedCity Pivot Podcast launches today with a conversation about how AI can be leveraged to transform precision medicine.
-
MedCity Influencers, Artificial Intelligence
Smart Medicine: Artificial Intelligence is Shaping Drug Discovery and Development in Ways Never Once Imagined
Traditionally, pharmaceutical companies have been slow to adopt these newer technologies, instead relying on well-established and proven – but usually complex – manufacturing processes. However, the time to begin investing in – and exploring – AI, machine learning, and big data is now.
-
Achieve Precision Medicine Through AI and Analytics Solutions
MedCity News connected with Integra Connect’s COO, Cory Wiegert at ViVE 2023 to discuss how their new platform will go beyond the “one size fits all” approach to data curation.
-
MedCity Influencers, Artificial Intelligence
Machine Learning Has Value, but It’s Still Just a Tool
Image recognition ML models are being widely used in radiology with excellent results, sometimes catching things missed by even the most highly trained human eye. This doesn’t mean ML is ready to replace clinicians’ judgment or take their jobs, but results so far offer compelling evidence that ML may have value as a tool to augment their clinical judgment.
-
Answers Healthcare Providers Need to 5 Burning AI Questions in Revenue Cycle Management
Automation, AI, and machine learning can all be used to identify issues that lead to denials, streamline the patient billing process, reduce manual processes, and provide real-time data to quickly process claims.
-
MedCity Influencers, Artificial Intelligence
The Case for Automatic Surveillance during Dialysis
This lack of monitoring is a serious problem—both for patients and for the overall healthcare system. The data show that in a typical dialysis center, each patient will suffer an average of 1.7 access blockages per year.
-
Edge Impulse’s Edge ML Series: Explore How to Deploy Advanced Edge ML at Scale
Invite-only, in-person event series for industry leaders like you. Join us to uncover product and ML innovation with our guests and speakers.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
MedCity Influencers, Artificial Intelligence, Health Tech
Trends to Watch For in “Ambient AI” at the Point of Care
Ambient AI promises a second coming for technology at the point of care enabling EHR systems to elegantly work for providers in the background, in natural workflows and “in conversation,” versus requiring the provider and patients to step aside, waste time, and “feed the beasts” of legacy transactional systems.
-
MedCity Influencers, Artificial Intelligence, Health Tech
Scaling Up IVF: How to Increase ROI and Build a (Re)productive IVF Business
By investing in the value chain of IVF with the right AI solutions, investors can solve the access problem growing in the IVF space, help more people build their families, and achieve significant ROI.
-
Artificial Intelligence, BioPharma
Why Sofinnova is Betting on the Confluence of Digital Technology and the Life Sciences
Paris-based Sofinnova Partners announced last week that it has launched a new strategy aimed at investing in a new breed of startups that straddle the lines between data and biology.
-
MedCity Influencers, Artificial Intelligence
The Role of AI in Addressing the Maternal Health Crisis
Over 800 women died from pregnancy-related complications in 2020 in the United States, and well […]
-
MedCity Influencers, Artificial Intelligence
When It Comes to Radiology, What Can We Teach ChatGPT ?
The potential of ChatGPT is exciting. Radiologists have come a long way on the AI journey. What started as a fear from some that AI would replace us, has evolved to a more nuanced understanding that AI’s greatest contribution in medical imaging is to make us better radiologists.
-
MedCity Influencers, Artificial Intelligence, Legal
AI Is at the Intersection of Safety and Equity in Healthcare
Hidden biases, reduced privacy, and over-reliance on non-transparent, decision-making black boxes can cut against democratic values, potentially putting our civil rights at risk. This means that the effective and equitable use of AI will be based on solving inherent ethical, safety, data privacy and cybersecurity challenges.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
